ResMed, Inc. Third Quarter Earnings Sneak Peek
ResMed, Inc. (NYSE:RMD) will unveil its latest earnings on Thursday, April 26, 2012. ResMed is a developer, manufacturer and distributor of medical equipment for treating, diagnosing and managing sleep-disordered breathing and other respiratory disorders.
ResMed, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for profit of 41 cents per share, a rise of 17.1% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved up from 39 cents. Between one and three months ago, the average estimate moved up. It has been unchanged at 41 cents during the last month. Analysts are projecting profit to rise by 11% compared to last year’s $1.62.
Last quarter, the company came in at net income of 42 cents per share against a mean estimate of profit of 38 cents per share, beating estimates after missing them in the previous quarter. In the first quarter, it missed forecasts by 2 cents.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 8.1% in revenue from the year-earlier quarter to $338.5 million.
Analyst Ratings: Of the 11 analysts surveyed, six (54.5%) rate ResMed a buy. This falls under the mean analyst rating of nine competitors, which average 65.9% buy ratings.
A Look Back: In the second quarter, profit rose 7.6% to $62.9 million (42 cents a share) from $58.5 million (37 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 8.7% to $332.7 million from $306 million.
Stock Price Performance: Between January 25, 2012 and April 20, 2012, the stock price rose $3.11 (11.4%), from $27.39 to $30.50. The stock price saw one of its best stretches over the last year between March 6, 2012 and March 15, 2012, when shares rose for eight straight days, increasing 8.8% (+$2.55) over that span. It saw one of its worst periods between July 19, 2011 and August 2, 2011 when shares fell for 11 straight days, dropping 9.3% (-$3.02) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: